» Articles » PMID: 38695054

Application of Genetic Information to Cochlear Implantation in Clinical Practice

Overview
Journal J Audiol Otol
Date 2024 May 2
PMID 38695054
Authors
Affiliations
Soon will be listed here.
Abstract

Cochlear implantation is currently the treatment of choice for children with severe-to-profound sensorineural hearing impairment (SNHI). However, the outcomes with cochlear implant (CI) vary significantly among recipients. Genetic diagnosis offers direct clues regarding the pathogenesis of SNHI, which facilitates the development of personalized medicine for potential candidates for CI. In this article, I present a comprehensive overview of the usefulness of genetic information in clinical decision-making for CI. Genetically confirmed diagnosis enables clinicians to: 1) monitor the evolution of SNHI and determine the optimal surgical timing, 2) predict the potential benefits of CI in patients with identified genetic etiology, and 3) select CI devices/electrodes tailored to patients with specific genetic mutations.

References
1.
Dhanasingh A, Hochmair I . CI in single-sided deafness. Acta Otolaryngol. 2021; 141(sup1):82-105. DOI: 10.1080/00016489.2021.1888496. View

2.
Chan D, Schrijver I, Chang K . Connexin-26-associated deafness: phenotypic variability and progression of hearing loss. Genet Med. 2010; 12(3):174-81. DOI: 10.1097/GIM.0b013e3181d0d42b. View

3.
Wu C, Lu Y, Chen P, Yeh P, Su Y, Hwu W . Phenotypic analyses and mutation screening of the SLC26A4 and FOXI1 genes in 101 Taiwanese families with bilateral nonsyndromic enlarged vestibular aqueduct (DFNB4) or Pendred syndrome. Audiol Neurootol. 2009; 15(1):57-66. DOI: 10.1159/000231567. View

4.
Lee C, Lin P, Chiang Y, Tsai C, Yang S, Chen Y . Genetic Underpinnings and Audiological Characteristics in Children With Unilateral Sensorineural Hearing Loss. Otolaryngol Head Neck Surg. 2023; 169(5):1299-1308. DOI: 10.1002/ohn.354. View

5.
Chen P, Tsai C, Wu J, Li Y, Wu C, Chen K . Hearing Features and Cochlear Implantation Outcomes in Patients With Pathogenic MYO15A Variants: a Multicenter Observational Study. Ear Hear. 2022; 43(4):1198-1207. DOI: 10.1097/AUD.0000000000001171. View